Gene Therapy pp 167-170 | Cite as

Modular Fusion Proteins for Receptor-mediated Gene Delivery

  • Christoph Uherek
  • Jesús Fominaya
  • Winfried Wels
Conference paper
Part of the NATO ASI Series book series (volume 105)


The development of vectors for target-cell specific gene delivery is a major goal of gene therapeutic strategies. Thereby non-viral gene delivery vectors are gaining increasing interest [1]. Progress has been made in the understanding how individual activities of viruses can be mimicked and methodologies have been developed which allow to combine different functions required for gene transfer into an artificial complex. An attractive approach for the design of such modular self-assembling systems for gene delivery is based on fusion proteins engineered to incorporate in a single polypeptide chain several cooperating functions [2–4]. Each of these domains can account for a distinct activity required for DNA-binding, cell recognition and intracellular delivery. Such fusion proteins in contrast to similar chemical conjugates can be produced in suitable expression systems in their final form and the resulting products are generally homogeneous in their composition.


Non-viral gene delivery fusion protein Pseudomonasexotoxin A diphtheria toxin GAL4 ErbB2 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cooper, M. J. Noninfectious gene transfer and expression systems for cancer gene therapy. Semin. Oncol. 23: 172–187, 1996.PubMedGoogle Scholar
  2. 2.
    Chen, S. Y., Zani, C., Khouri, Y., and Marasco, W. A. Design of a genetic immunotoxin to eliminate toxin immunogenicity. Gene Ther. 2: 116–123, 1995.PubMedGoogle Scholar
  3. 3.
    Fominaya, J. and Wels, W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. 271: 10560–10568, 1996.PubMedCrossRefGoogle Scholar
  4. 4.
    Paul, R. W., Weisser, K. E., Loomis, A., Sloane, D. L., LaFoe, D., Atkinson, E. M., and Overell, R. W. Gene transfer using a novel fusion protein, GAL4/invasin. Hum. Gene Ther. 8: 1253–1262, 1997.PubMedCrossRefGoogle Scholar
  5. 5.
    Hwang, J., Fitzgerald, D. J., Adhya, S., and Pastan, I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell. 48: 129–136, 1987.PubMedCrossRefGoogle Scholar
  6. 6.
    Choe, S., Bennett, M. J., Fujii, G., Curmi, P. M., Kantardjieff, K. A., Collier, R. J., and Eisenberg, D. The crystal structure of diphtheria toxin. Nature. 357: 216–222, 1992.PubMedCrossRefGoogle Scholar
  7. 7.
    Wels, W., Groner, B., and Hynes, N. E. Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2. Curr. Top. Microbiol. Immunol. 213: 113–128, 1996.PubMedCrossRefGoogle Scholar
  8. 8.
    Novoa, I., Gotten, M., and Carrasco, L. Hybrid proteins between Pseudomonas aeruginosa exotoxin A and poliovirus 2Apro cleave p220 in HeLa cells. J. Virol. 70: 3319–3324, 1996.PubMedGoogle Scholar
  9. 9.
    Carey, M., Kakidani, H., Leatherwood, J., Mostashari, F., and Ptashne, M. An aminoterminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 209: 423–432, 1989.PubMedCrossRefGoogle Scholar
  10. 10.
    Wagner, E., Cotten, M., Foisner, R., and Birnstiel, M. L. Transferrin-polyeation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl. Acad. Sci. USA. 88: 4255–4259, 1991.PubMedCrossRefGoogle Scholar
  11. 11.
    Wels, W. and Fominaya, J. Peptides and fusion proteins as modular DNA carriers. In L. W. Seymour, A. V. Kabanov, and P. L. Feigner (eds.), Self-assembling complexes for gene delivery: from chemistry to clinical trial. John Wiley & Sons Ltd., New York: 1998, in press.Google Scholar
  12. 12.
    Fisher, K. J. and Wilson, J. M. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem. J. 321: 49–58, 1997.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Christoph Uherek
    • 1
  • Jesús Fominaya
    • 2
  • Winfried Wels
    • 1
  1. 1.Institute for Experimental Cancer ResearchTumor Biology CenterFreiburgGermany
  2. 2.Department of Immunology and Oncology, Centro Nacional de Biotecnologfa/CSICUniversidad Autónoma de MadridMadridSpain

Personalised recommendations